Search Within

Solid Tumor Oncology Division

Formats
  1. Journal Article (11004)
  2. Meeting Abstract (9530)
  3. Review (575)
  4. Book Section (417)
  5. Editorial (341)
  6. Guidelines (161)
  7. Correspondence (120)
  8. Conference Paper (107)
  9. Research Letter (63)
  10. Miscellaneous (55)
  11. Book Whole (27)
Groups
  1. Department of Medicine (22376)
  2. GSK Faculty (5953)
  3. Genitourinary Oncology Service (5684)
  4. Survivorship Research (5261)
  5. Gastrointestinal Oncology Service (4738)
  6. Breast Medicine Service (4179)

More Groups

People
  1. Robert Motzer (1252)
  2. Howard Scher (1133)
  3. Clifford Hudis (906)
  4. Jedd Wolchok (905)
  5. Mark Kris (873)
  6. Eileen O'Reilly (800)

More People

Years
  1. 2025 (776)
  2. 2024 (1389)
  3. 2023 (1381)
  4. 2022 (1573)
  5. 2021 (1517)
  6. 2020 (1536)

More Years

Publications
  1. Journal of Clinical Oncology (5297)
  2. Annals of Oncology (1309)
  3. Cancer Research (1012)
  4. Clinical Cancer Research (781)
  5. Journal of Thoracic Oncology (534)
  6. Gynecologic Oncology (443)

More Publications

Publishers
  1. American Society of Clinical Oncology (5592)
  2. American Association for Cancer Research (2332)
  3. Elsevier Inc. (2239)
  4. Oxford University Press (1838)
  5. Nature Publishing Group (1053)
  6. Springer (992)

More Publishers

Results (22400)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Looking ahead! The feasibility of implementing remote patient monitoring for high-risk oncology patients
    Journal Article

    Mazzella-Ebstein, A.; Dunnack-Yackel, H.; Daly, R. M.; Salner, A. L.; Eanniello, M. K.; Fontaine, S.; Huang, J.; Bernal, C.; Wilhelm, C.; Ackerman, J.; more...
    BMC Health Services Research (2025)

    Fulltext@MSK | Save
  • Survival and patterns of failure in oligometastatic esophagogastric cancer
    Meeting Abstract

    Yariv, O.; Hilal, L.; Ku, G. Y.; Molena, D.; Janjigian, Y. Y.; Ilson, D. H.; Maron, S.; Sihag, S.; Strong, V. E.; Crane, C. H.; more...
    Radiotherapy and Oncology (2025)

    Fulltext@MSK | Save
  • ASCL1 and NEUROD1 are highly specific markers of lung vs digestive carcinoids/neuroendocrine tumors
    Meeting Abstract

    Willner, J.; Tarcan, Z.; Baine, M.; Armstrong, S.; Travis, W.; Wilson, C.; Bodd, F.; Tang, L.; Cooper, A.; Rudin, C.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Immunohistochemistry for the detection of STK11 (LKB1) genomic alterations in lung adenocarcinoma
    Meeting Abstract

    Saliba, M.; Febres-Aldana, C.; Baine, M.; Yang, S. R.; Sauter, J.; Travis, W.; Rudin, C.; Ladanyi, M.; Rekhtman, N.; Chang, J.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Integrated histological and molecular profiling of early-stage R0, resected non-mucinous lung adenocarcinomas
    Meeting Abstract

    Khan, I.; Aly, R. G.; Reiner, A.; Tan, K. S.; Rekhtman, N.; Chang, J.; Baine, M.; Chaft, J.; Travis, W.; Yang, S. R.
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • MTAP loss by immunohistochemistry predicts worse survival and poor response to pemetrexed chemotherapy in pleural mesothelioma
    Meeting Abstract

    Saliba, M.; Arfe, A.; Baine, M.; Bodd, F.; Chang, J.; Ortiz, E.; Wilson, C.; Linkov, I.; Mayoral, M.; Offin, M.; more...
    Laboratory Investigation (2025)

    Fulltext@MSK | Save
  • Nivolumab plus relatlimab vs nivolumab alone for the adjuvant treatment of completely resected stage III-IV melanoma: Primary results from RELATIVITY-098
    Meeting Abstract

    Long, G. V.; Ascierto, P. A.; Guo, J.; Chandra, S.; Tarhini, A. A.; Couselo, E. M.; Del Vecchio, M.; De Melo, A. C.; Gogas, H.; Dummer, R.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Tarlatamab versus chemotherapy (CTx) as second-line (2L) treatment for small cell lung cancer (SCLC): Primary analysis of Ph3 DeLLphi-304
    Meeting Abstract

    Rudin, C. M.; Mountzios, G. S.; Sun, L.; Cho, B. C.; Demirci, U.; Baka, S.; Gumus, M.; Lugini, A.; Ciuleanu, T. E.; Ahn, M. J.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase 3 AMPLITUDE trial: Niraparib (NIRA) and abiraterone acetate plus prednisone (AAP) for metastatic castration-sensitive prostate cancer (mCSPC) patients (pts) with alterations in homologous recombination repair (HRR) genes
    Meeting Abstract

    Attard, G.; Agarwal, N.; Graff, J. N.; Sandhu, S.; Efstathiou, E.; Özgüroğlu, M.; de Santana Gomes, A. J. P.; Vianna, K. C. M.; Luo, H.; Cheng, H. H.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • First-line encorafenib + cetuximab + mFOLFOX6 in BRAF V600E-mutant metastatic colorectal cancer (BREAKWATER): Progression-free survival and updated overall survival analyses
    Meeting Abstract

    Elez, E.; Yoshino, T.; Shen, L.; Lonardi, S.; Van Cutsem, E.; Eng, C.; Kim, T. W.; Wasan, H. S.; Desai, J.; Ciardiello, F.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save